A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 21,719 shares of MRNA stock, worth $874,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,719
Previous 22,373 2.92%
Holding current value
$874,624
Previous $2.66 Million 45.37%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $41,620 - $81,841
-654 Reduced 2.92%
21,719 $1.45 Million
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $50,908 - $83,804
-503 Reduced 2.2%
22,373 $2.66 Million
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $70,174 - $94,891
-822 Reduced 3.47%
22,876 $2.44 Million
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $71,039 - $106,727
-1,022 Reduced 4.13%
23,698 $2.36 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $17,932 - $23,549
-186 Reduced 0.75%
24,720 $2.55 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $44,319 - $60,038
-374 Reduced 1.48%
24,906 $3.03 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $126,666 - $224,742
-1,070 Reduced 4.06%
25,280 $4.54 Million
Q3 2022

Nov 16, 2022

BUY
$118.07 - $194.18 $3.11 Million - $5.12 Million
26,350 New
26,350 $3.12 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $0 - $0
0 New
0 $3.12 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $702 - $1,059
-6 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $126 - $235
1 Added 20.0%
6 $1,000
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $1,129 - $1,842
5 New
5 $1,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.